GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCGet Free Report) have received a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $88.83.

GEHC has been the subject of a number of research analyst reports. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their price target for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 price target for the company. Morgan Stanley upped their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Jefferies Financial Group initiated coverage on GE HealthCare Technologies in a report on Thursday, November 30th. They set a “hold” rating and a $80.00 target price on the stock. Finally, Mizuho upped their price target on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 7th.

Get Our Latest Research Report on GEHC

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Command Advisory Services Inc. lifted its holdings in shares of GE HealthCare Technologies by 36,900.0% in the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after purchasing an additional 369 shares in the last quarter. Pin Oak Investment Advisors Inc. purchased a new position in GE HealthCare Technologies during the 2nd quarter valued at about $25,000. Center for Financial Planning Inc. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $26,000. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of GE HealthCare Technologies in the third quarter worth approximately $26,000. Finally, Legacy Financial Group LLC acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $26,000. Institutional investors and hedge funds own 79.18% of the company’s stock.

GE HealthCare Technologies Stock Up 1.3 %

Shares of GE HealthCare Technologies stock opened at $93.87 on Friday. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies has a 1-year low of $62.35 and a 1-year high of $94.50. The business’s fifty day moving average price is $81.05 and its two-hundred day moving average price is $73.39. The company has a market capitalization of $42.74 billion, a P/E ratio of 31.08, a PEG ratio of 3.24 and a beta of 0.97.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company’s revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.31 earnings per share. As a group, research analysts forecast that GE HealthCare Technologies will post 4.3 EPS for the current year.

About GE HealthCare Technologies

(Get Free Report

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Recommended Stories

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.